Diligence memo · auto-generated · as of July 2, 2026

MedVet Associates, LLC

MedVet Associates, LLC looks under-valued against its niche peers and is quiet on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

MedVet Associates, LLC operates in Other, based in WORTHINGTON.

Sector still resolves to a broad 'Other' bucket, so operating comparables below are weaker than for a tightly-classified peer.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

MedVet Associates, LLC has raised $368M in disclosed capital across 36 recorded rounds, aggregated from public filings. Its latest round is modeled as Series D+ (a $100M–$400M round).

Largest single filing: $226M on 2019-07-15.

Most recent recorded round closed around 2025-03-31.

Filings read as a recurring offering program rather than a clean venture-stage ladder — interpret stage labels and step-ups with that in mind.

Valuation (modeled)modeled

Provath models MedVet Associates, LLC at approximately $20M (range $14M–$26M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.02× the median modeled value of Series D+ Other companies in 2025–2027 (50 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 3 months.

Last raise 15 mo ago; this sector typically re-raises about every 11 months.

Slightly overdue versus sector cadence.

The last round was 1.3× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 99% of Other peers (25015 compared).

Modeled value ranks above 53% of those peers.

Closest niche peers: AP Adhesives Acquisitions, Inc., INNOVATE Corp., Curaleaf Holdings, Inc., Phantom Parent, LP, Impulse Space, Inc..

Peoplefiled

21 named people on file across officers, directors and signatories.

Risks & flagsmixed

Broad sector classification weakens peer comparison.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.

Recurring-offering pattern: stage-based valuation has lower applicability.